Eli Lilly and Company (NYSE:LLY) Special Call (Lilly Investor Event at American Diabetes Association's (ADA) 85th Scientific Sessions) Conference June 22, 2025 7:30 PM ET
Company Participants
Jeffrey Emmick - Vice President of Diabetes Product Development
Kenneth L Custer - Executive VP & President of Lilly Cardiometabolic Health
Michael Czapar - Director of Investor Relations
Ruth Gimeno - Corporate Participant
Conference Call Participants
Akash Tewari - Jefferies LLC, Research Division
Alexandria Janet Hammond - Wolfe Research, LLC
Bryan Russell Dollinger - Leerink Partners LLC, Research Division
Courtney Breen - Sanford C. Bernstein & Co., LLC., Research Division
Geoffrey Christopher Meacham - Citigroup Inc., Research Division
James John Shin - Deutsche Bank AG, Research Division
Jeffrey Holford - T. Rowe Price Associates, Inc.
Mohit Bansal - Wells Fargo Securities, LLC, Research Division
Rajesh Kumar - HSBC, Research Division
Seamus Christopher Fernandez - Guggenheim Securities, LLC, Research Division
Terence C. Flynn - Morgan Stanley, Research Division
Trung Chuong Huynh - UBS Investment Bank, Research Division
Michael Czapar
All right. Well, good evening, everybody. Thank you for joining us. I know it's probably been a long conference already, but we're very happy to host you here tonight at the -- in Chicago at the ADA Scientific Sessions. I'm Mike Czapar. I'm Senior Vice President of Investor Relations for Eli Lilly. Very happy to spend some time with you this evening.
On Slide 3, we have the agenda. So we've got 3 speakers. We'll do some presentation, prepared remarks, followed by a question-and- answer panel. So to kick things off, Ken Custer, who is our President for Cardiometabolic Health, will give an introduction and give some backdrop on the cardiometabolic health strategy. We'll then hear from Dr. Jeff Emmick, who is our Senior Vice President for Cardiometabolic Health Product Development. He'll walk through some of our recently presented orforglipron data, ACHIEVE-1, as well as highlight some key events for the
- Read more current LLY analysis and news
- View all earnings call transcripts